Innovex International (INVX) EBT (2009 - 2026)

Innovex International (INVX) has reported EBT for 18 consecutive years, with $35.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 59.23% year-over-year to $35.4 million; the trailing twelve-month figure through Jun 2026 stood at $98.7 million (down 86.19% YoY), and the FY2025 full-year result was $128.5 million, down 81.81% from the prior year.
• EBT grew to $35.4 million in Q2 2026 per INVX's latest filing, from -$21.6 million in the prior quarter.
• Across five years, EBT topped out at $591.3 million in Q4 2024 and bottomed at -$21.6 million in Q1 2026.
• Historically, EBT has averaged $54.5 million across 5 years, with a median of $21.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: EBT jumped 2417.46% in 2024, then plunged 201.08% in 2026.
• Over 5 years, EBT stood at $69.1 million in 2022, then plunged by 66.0% to $23.5 million in 2023, then surged by 2417.46% to $591.3 million in 2024, then sank by 95.44% to $27.0 million in 2025, then surged by 31.3% to $35.4 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $35.4 million, -$21.6 million, and $27.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.